This process establishes a positive feedback loop, wherein the upregulation of GLUT1 further enhances the glucose uptake capacity of malignant cells, promoting tumor evolution while suppressing the anti-tumor activity of CD8+ T cells. Here, SLC2A1 is linked to neoplasm.